1.
              Curcio A, Torella D, Indolfi C (2011) Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 75: 128796. 
                      Find this article online
                    
2.
              Wight TN (2008) Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 13: 49337. 
                      Find this article online
                    
3.
              Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, et al. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 274: 2508592. 
                      Find this article online
                    
4.
              Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev. 91: 22164. 
                      Find this article online
                    
5.
              Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 85: 699715. 
                      Find this article online
                    
6.
              Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, et al. (2005) Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res. 96: 58391. 
                      Find this article online
                    
7.
              Nagy N, Freudenberger T, Melchior-Becker A, Rock K, Ter Braak M, et al. (2010) Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation. 122: 231322. 
                      Find this article online
                    
8.
              Riessen R, Wight TN, Pastore C, Henley C, Isner JM (1996) Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 93: 11417. 
                      Find this article online
                    
9.
              Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, et al. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol. 170: 108699. 
                      Find this article online
                    
10.
              Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, et al. (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol. 172: 17993. 
                      Find this article online
                    
11.
              Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, et al. (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A. 99: 71427. 
                      Find this article online
                    
12.
              Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, et al. (2004) Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A. 101: 171327. 
                      Find this article online
                    
13.
              Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, et al. (2008) Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation. 117: 307987. 
                      Find this article online
                    
14.
              Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, et al. (2000) A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 32: 2097104. 
                      Find this article online
                    
15.
              Tanaka K, Sata M, Hirata Y, Nagai R (2003) Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 93: 78390. 
                      Find this article online
                    
16.
              Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, et al. (2007) M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol. 27: 2839. 
                      Find this article online
                    
17.
              Yokouchi K, Numaguchi Y, Kubota R, Ishii M, Imai H, et al. (2006) l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler Thromb Vasc Biol. 26: 22317. 
                      Find this article online
                    
18.
              Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, et al. (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 22: 16428. 
                      Find this article online
                    
19.
              Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, et al. (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res. 70: 619. 
                      Find this article online
                    
20.
              Yoshihara S, Kon A, Kudo D, Nakazawa H, Kakizaki I, et al. (2005) A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett. 579: 27226. 
                      Find this article online
                    
21.
              Nakamura T, Takagaki K, Shibata S, Tanaka K, Higuchi T, et al. (1995) Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem Biophys Res Commun. 208: 4705. 
                      Find this article online
                    
22.
              Fischer JW, Schror K (2007) Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost. 98: 28795. 
                      Find this article online
                    
23.
              Zhao L, Lee E, Zukas AM, Middleton MK, Kinder M, et al. (2008) CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 28: 12839. 
                      Find this article online
                    
24.
              Davis C, Fischer J, Ley K, Sarembock IJ (2003) The role of inflammation in vascular injury and repair. J Thromb Haemost. 1: 1699709. 
                      Find this article online
                    
25.
              Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, et al. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest. 108: 103140. 
                      Find this article online
                    
26.
              Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, et al. (1995) Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest. 95: 115868. 
                      Find this article online
                    
27.
              Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, et al. (2006) Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res. 72: 33948. 
                      Find this article online
                    
28.
              Jain M, He Q, Lee WS, Kashiki S, Foster LC, et al. (1996) Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 98: 877. 
                      Find this article online
                    
29.
              Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, et al. (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem. 279: 332819. 
                      Find this article online
                    
30.
              Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, et al. (2009) The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology. 19: 53746. 
                      Find this article online
                    
31.
              Murayama H, Takahashi M, Takamoto M, Shiba Y, Ise H, et al. (2008) Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Cardiovasc Res. 80: 17580. 
                      Find this article online
                    
32.
              Stacchino C, Spano R, Pettiti A (1983) Spasmolytic activity of some 4-methylumbelliferone derivatives. Boll Chim Farm. 122: 15860. 
                      Find this article online
                    
33.
              Fontaine L, Grand M, Molho D, Chabert MJ, Boschetti E (1968) [Choleretic, spasmolytic and general pharmacologic activities of 4-methylumbelliferone]. Therapie. 23: 5162. 
                      Find this article online
                    